SEC Form D · Amendment · filed April 23, 2021
Revelation Biosciences, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (18)
Jess F. Roper · San Diego, CADirectorJames M. Rolke · San Diego, CAExec · DirectorSven Borre Larsen · Oslo, Q8Exec · DirectorGrethe Moen · Oslo, Q8DirectorDavid Welch · Oakland, CAExec · DirectorJan Schoolmeesters · Oslo, Q8DirectorCurt F. Labelle · San Diego, CADirectorMatt Blodgett · San Francisco, CADirectorChristopher Finlayson · Oslo, Q8DirectorGeorge F. Tidmarsh · San Diego, CADirectorJulian N. Fletcher · Grand Cayman, Cayman IslandsDirectorChester S. Zygmont Iii · San Diego, CAExecIrene Egset · Oslo, Q8ExecNavus Capital Management LP · Oakland, CADirectorJennifer F. Carver · San Diego, CADirectorRajan Lukose · Oakland, CADirectorDoonaye Sookye · Morc St Andre, O4DirectorRajiv Seetul · Beau Bassin, O4Exec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗